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Abstract
Background: Breast cancer screening continues to be underutilized by the population in general, but is particularly
underutilized by traditionally underserved minority populations. Two of the most at risk female minority groups are
American Indians/Alaska Natives (AI/AN) and Latinas. American Indian women have the poorest recorded 5-year
cancer survival rates of any ethnic group while breast cancer is the number one cause of cancer mortality among
Latina women. Breast cancer screening rates for both minority groups are near or at the lowest among all racial/
ethnic groups. As with other health screening behaviors, women may intend to get a mammogram but their
intentions may not result in initiation or follow through of the examination process. An accumulating body of
research, however, demonstrates the efficacy of developing ‘implementation intentions’ that define when, where,
and how a specific behavior will be performed. The formulation of intended steps in addition to addressing
potential barriers to test completion can increase a person’s self-efficacy, operationalize and strengthen their
intention to act, and close gaps between behavioral intention and completion. To date, an evaluation of the
formulation of implementation intentions for breast cancer screening has not been conducted with minority
populations.
Methods/Design: In the proposed program, community health workers will meet with rural-dwelling Latina and
American Indian women one-on-one to educate them about breast cancer and screening and guide them
through a computerized and culturally tailored “implementation intentions” program, called Healthy Living Kansas -
Breast Health, to promote breast cancer screening utilization. We will target Latina and AI/AN women from two
distinct rural Kansas communities. Women attending community events will be invited by CHWs to participate and
be randomized to either a mammography “implementation intentions” (MI2) intervention or a comparison general
breast cancer prevention informational intervention (C). CHWs will be armed with notebook computers loaded
with our Healthy Living Kansas - Breast Health program and guide their peers through the program. Women in the
MI2 condition will receive assistance with operationalizing their screening intentions and identifying and
addressing their stated screening barriers with the goal of guiding them toward accessing screening services near
their community. Outcomes will be evaluated at 120-days post randomization via self-report and will include
mammography utilization status, barriers, and movement along a behavioral stages of readiness to screen model.
Discussion: This highly innovative project will be guided and initiated by AI/AN and Latina community members
and will test the practical application of emerging behavioral theory among minority persons living in rural
communities.
Trial Registration: ClinicalTrials (NCT): NCT01267110
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Background
Breast cancer is the most common malignancy among
Hispanic women in the United States and is the leading
cause of death from cancer [1]. Breast cancer is the sec-
ond leading cause of cancer death among AI/AN
women [2]. Breast cancer-specific 5-year survival rates
for AI/AN women (84.0%) and Latinas (85.8%) are
among the lowest of any racial ethnic group in the Uni-
ted States. Only African American and Other Pacific
Islander women have lower 5-year survival rates [3].
While breast cancer mortality rates have steadily fallen
for most racial/ethnic groups, mortality rates have
increased among AI/AN women [4]. Hispanic/Latina
women are more likely to be diagnosed at a later stage
than non-Hispanic white women [5]. During 2000-2003,
54% of Hispanic women were diagnosed with local stage
cancer compared to 63% of non-Hispanic white women
[1]. AI/AN women were also more likely than Whites to
be diagnosed with late stage disease [6]. Diagnostic stage
disparities are most likely secondary to under utilization
of routine mammography.
While not all breast cancers are identified by mammo-
graphy, it is the most effective method for detecting
cancer at the earliest most treatable stage [7]. Results of
randomized trials and population-based screening
evaluations have demonstrated that regular screening
mammography can reduce breast cancer mortality [7].
Unfortunately, many minority and underserved women
remain unscreened or are screened infrequently and
thus are at risk for late stage at diagnosis and for
increased mortality from breast cancer. In fact, AI/AN
and Latina women have consistently had the lowest
screening rates of all racial/ethnic groups [7].
Barriers to Mammogram Utilization
A number of factors play a role in keeping mammogra-
phy utilization at less than optimal levels. Numerous
barriers have been identified that impede women from
completing breast cancer screening. As with other
health screening behaviors, women may intend to get a
mammogram but their intentions may not result in
initiation or follow through of the examination process
[8], due, in part, to getting hung up on one or more
barriers inherent in the mammography scheduling,
examination, and follow-up process. Studies conducted
with AI/AN women and Latinas have found similar bar-
riers to those of other racial and ethnic groups. Screen-
ing barriers among Latinas and AI/AN women include
fear of pain [9,10]; beliefs [9,10]; and embarrassment
[9,11]; and lack of health insurance [9-12]. Mack et al.
report that “lack of affordability was the most frequently
cited perceived barrier to screening among Latinas over-
due for screening” [13]. More than twice as many
Hispanics report no usual source of care than do white
non-Hispanics, 35% versus 15% [14]. Transportation and
cost and taking time off from work [11] also influence
the screening decisions of Latinas [13]. Women with
less than a high school education, who have no health
insurance coverage, and who are recent immigrants, are
least likely to have had a recent mammogram [15].
Language is an additional barrier for many Latinas [9]
and some AI/AN women [16].
Daley et al. of our research team conducted focus
groups with AI community leaders and providers in
Northeast Kansas. This study found that mammogra-
phy cost and transportation were key among the
reported barriers to screening. AI/AN women without
health insurance must pay out of pocket for mammo-
grams if the Indian Health Service clinic where they
receive care does not offer mammograms. Focus group
participants recommended culturally tailored written
and oral materials containing specific information
about how and where to get a mammogram as a
means to improve utilization among AI/AN women.
They also recommended outreach to culturally relevant
events and locations.
Access to Mammography
Access issues that may be classified as barriers to mam-
mography include limited hours of mammography facil-
ity operation, acceptance of self-referrals, ease of making
an appointment, waiting room time, the use of reminder
postcards or telephone calls, and location/type of facility.
For the AI/AN population, this may also entail the per-
vasive unavailability of Indian Health Service practi-
tioners and facilities. For example, all enrolled members
of federally-recognized tribes are eligible for free health
services at Indian Health Service (IHS) facilities and
most AI/AN receive at least some of their care at IHS
facilities. The IHS has 12 area offices overseeing 550
healthcare facilities across the US. The IHS does not
have funding to place mammography machines in all
clinics or to transport women to clinics that have them
[17]. As such, many women go outside the IHS for
breast cancer screening.
The IHS Holton Service Unit in Northeast Kansas is
comprised of one IHS health center (White Cloud
Health Station) and two tribal health centers (Kickapoo
Health Center and Prairie Band Potawatomi Family
Health Center). Four American Indian Nations (Kicka-
poo; Iowa Tribe of Kansas and Nebraska; Prairie Band
Potawatomi; Sac and Fox) reside within this region.
The Holton Service Unit area office is staffed by a vari-
ety of medical professionals including physicians,
family nurse practitioners, nurses, a pharmacist, and
diabetic health educators. The Holton Service Unit
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serves a five county area (Brown, Jackson, Doniphan,
Jefferson, and Pottawatomie).
The Four Tribes Women’s Wellness Program, at the
Prairie Band Potawatomi Family Health Center, pro-
vides outreach services for the Kansas Early Detection
Works program. Women without health insurance or
who are underinsured ($2500 unmet deductable), and
who are 50-64 years of age, are eligible for free breast
and cervical cancer screening and are given a voucher
to receive a mammogram at no charge. The Kansas
Department of Health and Environment also enrolls
women 40-49, meeting the same criteria, in a parallel
program funded by the Susan G. Komen for the Cure
Foundation.
In Garden City, KS, women enrolled in the Early
Detection Works program are screened for cervical can-
cer and receive a clinical breast exam at one of two
locations: the Finney County Health Department or the
United Methodist Mexican-American Ministries clinic.
Latinas enrolled in the Early Detection Works program
or the Susan G. Komen for the Cure program, are given
a mammogram voucher. The Health Department’s
bi-lingual outreach worker helps women schedule a
mammogram at a local hospital. Many of the Latinas in
Garden City are employed by one of the two meat
packing plants located in or near Garden City. While
some of these women have health insurance through
their employers, they face transportation barriers and
may be reluctant, or unable, to take time-off to obtain
routine screening.
Avenues to Reach the Rural Kansas Latino and AI
Communities
A recent study highlights the role of community pro-
grams for outreach to poor and minority women and
recommends careful consideration of community based
and other approaches outside of the traditional purview
of medical care to encourage use of mammography
among hard to reach women [18]. Community and
church-based events may be perfect venues for reaching
and educating underserved minority women who have
limited access to mammography [19]. In fact, commu-
nity health fairs nationwide have grown to become an
integral part of reaching Latinos to provide education,
screening, and referral to community health resources.
Community health fairs fill critical healthcare needs in
many Latino communities. In addition to these efforts,
academic and religious institutions, philanthropic and
social service agencies in communities across the coun-
try have joined to support health fairs to serve Latino
communities by reaching the underserved and connect-
ing individuals to community clinics and related health
resources.
Rationale for Framing the Project Within the Precaution
Adoption Process Model (PAPM) and Incorporating the
Concept of Implementation Intentions into an
Intervention to Promote Breast Cancer Screening
The PAPM and the concept of “implementation inten-
tions” form the basis for our intervention approach
[20,21]. Factors addressed by the intervention will be
individualized based on computerized assessments that
document a PAPM stage, collect information on barriers
to and perceptions around breast cancer screening and,
for the MI2 intervention arm participants, identify each
participant’s implementation intentions for scheduling,
getting to and receiving a mammogram.
The PAPM was chosen for this study because it
includes specific stages for “unaware” and actively
“deciding” individuals. “Awareness” and some degree of
breast cancer screening knowledge may be a necessary
precursor to behavioral interventions intending to
advance screening adherence [22]. Recent studies of tai-
lored health communications and behavioral counseling
have shown that among individuals with no knowledge
of a given area of health, interventions have little effect
on promoting related healthy behaviors [23,24]. For
breast cancer screening, “awareness” and knowledge def-
icits may be an especially salient issue among our two
targeted minority populations (Latinas and American
Indian/Native Alaskans).
Although prior breast cancer screening interventions
have delivered programs to encourage participants to
move from intentions to action by emphasizing the
importance of breast cancer screening, more may be
necessary to help participants identify and specifically
agree to the intermediate action steps leading to com-
pletion of screening. For those in a less advanced PAPM
stage ("Unaware,” “Unengaged,” and “Deciding”), this
might involve identifying and agreeing to contact health
care and peer information sources to learn more about
the pros and cons of screening. For those individuals
who have decided to be screened, this might involve
stating exactly when and who the patient will contact to
set up a screening test.
Our model assumes that, for many rural dwelling
Latina and AI/AN women, much needs to be done to
move from intent to be screened (motivation) to actual
breast cancer screening action and follow through (voli-
tion). Emerging behavioral theory offers improved theo-
retical constructs for addressing this issue. For example,
theoretical elaborations of the Theory of Planned Beha-
vior [25,26] and the Theory of Reasoned Action [27,28],
which emphasize the need to consider “implementation
intentions,” have garnered empirical support across a
variety of behavioral outcomes, including smoking cessa-
tion, condom use and sexual behavior, and cancer
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screening [29,30]. This emerging body of research high-
lights the advantages of encouraging target groups to
develop tailored action plans that specify the “when”,
“where” and “how” the intention will be activated.
It is believed that there are two stages–motivational
and volitional–through which people pass before per-
forming a behavior [31,32]. The motivational stage
involves one’s orientation toward engaging in the beha-
vior and culminates in the formation of a behavioral
intention. The volitional stage culminates in the actual
performance of the behavior in question. Thus, whereas
models such as the Theory of Planned Behavior [25]
provide clear guidance as to what motivates people (e.g.,
behavioral intentions), they are less clear about how
motivation is translated into action. Gollwitzer’s [29]
concept of implementation intentions is important in
this regard. Implementation intentions are volitional
strategies that can be used to ensure that behavioral
intentions are translated into action. Whereas behavioral
intentions (e.g., “I plan to have a mammogram in the
next three months”) summarize one’s motivation to
engage in behavior, implementation intentions are plans
that specify the conditions under which a target
behavior will be performed (e.g., “I will schedule a mam-
mogram for Friday, September 16th by calling the
scheduling clerk at XYZ mammography facility”). As
described initially by Gollwitzer and colleagues [29],
implementation intentions characterize a process
of strategic automaticity whereby the initiation of
goal-directed responses becomes more automatic and is
possible without as much direct conscious intent. Inter-
vention strategies using implementation intentions have
been successful in clinically linked settings. For example,
Sheeran and Orbell [30] showed that an implementation
intention intervention increased attendance at cervical
cancer screening by more than 20% compared with a
control group. Implementation intentions have also
been shown to increase vitamin supplement intake [33],
breast self-examination [34], vigorous physical activity
[35], and functional ability after surgery [36].
As with the PAPM, implementation intentions have
been shown most applicable for deliberate or one-time
actions. For the proposed study we see implementation
intentions as having primary salience within the have
“decided to get screened” stage of the PAPM, but they
also can have information seeking applicability at the
“unaware,” “unengaged,” “deciding,” and “decided not
to” stages (see Figure 1). Implementation intentions pro-
vide a useful mechanism for helping individuals think
through a plan to handle barriers interfering between a
Figure 1 The Integrated Precaution Adoption Process Model and Implementation Intentions Concept Applied to Breast Cancer
Screening.
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decision to act and the completion of the action (if near
an Action stage) or seek more information (if they are
near a Pre-action stage). Judging from prior studies
which have shown a robust effect with “implementation
intentions” interventions [21,30,37-39], participant’s
statements of the specific “how,” “when,” and “where”
they will complete breast cancer screening should shar-
ply enhance examination completion, even when the
process may be considered “Inconvenient”, “invasive”,
“painful” or “unpleasant.”
Conceptual Model: Applying the Precaution-Adoption
Process Model and Implementation Intentions to Breast
Cancer Screening
The proposed research is grounded within the frame-
work of the Precaution Adoption Process Model
(PAPM) [40,41] and the concept of ‘implementation
intentions’ [21,30,42]. Variables and concepts essential
for tailoring implementation intentions along the PAPM
stages are shown inside stage boxes in parentheses in
Figure 1. The Precaution Adoption Process Model posits
that individuals are staged along a behavioral conti-
nuum. Participants with no knowledge of breast cancer
screening would be considered to be in stage 1 - “una-
ware.” In a pilot cancer screening study completed by
our Healthy Living Kansas research team, the vast
majority of participants were able to move beyond the
‘unaware’ stage in our pilot projects after a brief educa-
tional session. At the end of session, 95% of participants
stated they intended to complete colon cancer screening
and accepted FOBT kits. Subsequently, only 22% of
those accepting cards sent them in prior to a reminder
call. This suggests that many individuals will report that
they have “decided to be screened” but many may
actually be in a “deciding” stage. Our intervention, as
outlined in Figure 1, will be tailored to “Action Imple-
mentation Intentions” for those who have “decided to
be screened” (stage 5) and “Pre-Action Implementation
Intentions” for those who are “unaware” or have low
perceived breast cancer susceptibility and need to seek
information resources (health care provider, peers, etc.).
We believe this “unengaged” (stage 2), still “deciding”
(stage 3), or has “decided not to be screened” (stage 4)
cohort will be significantly smaller than the have
“decided to be screened” group.
As described above in the Background section, the
Precaution Adoption Process Model (PAPM), developed
by Weinstein and colleagues, is a stage theory of health
behavior [40]. Stage theories attempt to define the pro-
cess of behavior change and the series of steps required
to fulfill behavior change. The PAPM describes the
adoption of new preventive behaviors (precautions) and
cessation of health-risk behaviors. The PAPM addresses
an individual’s awareness and the junctures along the
decision-making process. Once an action decision is
reached there still may be specific barriers to completing
a specified action. It is best suited to behaviors with
deliberate action rather than habitual patterns that
develop gradually over time [43].
The PAPM has been applied to health behaviors
including mammography [44], osteoporosis prevention
[45] and management [46], and home radon testing
[47]. While other stage-based health behavior theories
have been applied to cancer screening [48,49], use of
the PAPM with the implementation intentions concept
is novel. Like other screening tests for colon, cervical,
and prostate cancer, many women, including minorities,
demonstrate a lack of awareness and/or knowledge
about breast cancer and screening. Therefore, a model
such as the PAPM that addresses people who are una-
ware of their risk or their screening options is
appropriate.
In general, health behavior theories assume a certain
level of knowledge about the health issue in question.
After all, people need to know something to form per-
ceptions and attitudes about the behaviors that lead to
or prevent disease. Lack of awareness of the issue
defines the PAPM’s first stage. In the second stage, peo-
ple become aware but are not yet at a point where they
are actively considering the precautionary behavior. An
individual in this stage lacks engagement due to inade-
quate personal relevance. Perceived susceptibility is pre-
sumed to be important at this stage. If, and when,
people become engaged in the issue, they progress to a
decision-making phase (Stage 3). Self-efficacy, barriers,
and any prior experience with the screening test might
be important in this decisional stage. Decision-making
can result in a decision not to act (Stage 4) or a decision
to act (Stage 5). However, deciding to act is not the final
step in the process. It is at the decisional point that new
barriers or low self-efficacy can again become apparent
and need to be addressed directly. We propose addres-
sing these issues through an application of the “imple-
mentation intentions” construct and have labeled this
Action Implementation Intentions in the gap between
decision and test completion. Our prior work [50] and
other studies [8] have shown that even once a decision
has been made and individuals are motivated to com-
plete cancer screening, many individuals still fail to fol-
low through with volitional features of testing
procedures. This gap between decision and action is not
unique to the PAPM [25,51].
The development of plans to overcome specific logis-
tic or perceptual barriers can facilitate the translation of
intent into action. For breast cancer, the decision to get
screened may be separate from the decision of where to
go to obtain screening services. Multiple steps are
clearly involved in following through with test schedul-
ing, completion, and follow-up. Our proposed project
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will explore and define these constructs as they apply to
breast cancer prevention; the culturally sensitive inter-
vention will test the model and its assumptions, and a
120-day post randomization follow-up survey will con-
firm participant progression through PAPM stages,
determine changes in reported breast cancer screening
barriers, and evaluate response to implementation inten-
tions among minority women.
This study was approved by the University of Kansas
Medical Center Human Subjects Review Committee.
Study Aims And Hypotheses
Aim #1
To compare the 120-day post randomization mammo-
graphy screening completion rates of individuals who
receive a computerized mammography “implementation
intentions” (MI2) intervention, versus a comparison
computerized condition of general breast cancer preven-
tion health education (C).
Hypothesis
Not up-to-date or never screened individuals who
receive a mammography “implementation intentions”
intervention (MI2) will be significantly more likely to
complete a screening mammography test at 120 days
post randomization than those receiving a general breast
cancer prevention health education intervention (C).
Aim #2
To compare the screening mammography self-reported
barriers after 120-days post randomization between those
receiving a mammography “implementation intentions”
intervention (MI2) and those receiving only a general
breast cancer prevention health education intervention (C).
Hypothesis
Those who receive the MI2 intervention will report
fewer barriers to screening mammography completion
than those receiving a general breast cancer prevention
health education intervention (C).
Aim #3
To compare changes in mammography screening Pre-
caution Adoption Process Model decisional stage from
baseline to 120 days post randomization between indivi-
duals in the MI2 and C study arms.
Hypothesis
Individuals who receive the MI2 intervention will show
significantly more movement in PAPM stage at 120 days
post randomization than those receiving a general breast
cancer prevention health education intervention (C).
Methods/Design
Study 1: Development - Formative Research
This study is a randomized intervention testing the effi-
cacy of a novel intervention program for increasing
breast cancer screening use among rural minority
women. The study employs a partnership intervention
between Community Health Workers and Latina and
American Indian women to provide breast cancer edu-
cation and promote the use of an ‘implementation
intentions-based’ approach for breast cancer screening
(See Table 1: Implementation Plan). Eligible (i.e., 40
years of age or older and not up-to-date on breast can-
cer screening), consenting participants will complete a
baseline computerized Healthy Living Kansas-Breast
Health (HLK-BH) assessment while attending one of
many community or church-based events scheduled
within their respective home community. The HLK-BH
program will gather data on past breast cancer screening
behavior, breast cancer screening barriers, perceived
breast cancer susceptibility and screening self-efficacy.
Consenting age-eligible, not up-to-date participants will
be randomized to a mammography “implementation
intentions” intervention arm (MI2) or a control (C) arm
(described in detail below). Participants will be enrolled
from well attended community events scheduled on an
annual basis in and around Mayetta in northeast Kansas
(to capture the American Indian population) and Gar-
den City in southeast Kansas (an area highly populated
with Latinos). Details regarding site selection, randomi-
zation, intervention methods, sample size calculations,
and data analysis procedures are described below. We
project that 121 women 40+ years old and not up-to-
date with mammography screening will be required for
each of the study arms to detect the proposed interven-
tion effects.
Design
This study will be a randomized trial that will evaluate
the differential impact of the MI2 (intervention) and C
Table 1 Implementation Plan
Study Tasks Year
Study 1: Development and
Formative Research
Refine computer program, refine assessments (e.g., HLK-Breast Health, 120-day post randomization
telephone follow-up), convene community advisory board, pilot test full HLK-Breast Health computer
program.
1 - 2
Study 2: Randomized Trial Finalize recruitment procedures, implement HLK-Breast Health program and 120-day post randomization
telephone follow-up, perform preliminary data cleaning and initial data analysis.
3 - 5
Study 3: Data Analysis and
Dissemination
Complete data cleaning, data analysis, project-related manuscripts, and follow-up grant development. 4 - 5
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(control) study arms on 120-day post randomization
breast cancer screening utilization rates. Randomization
will occur at the participant level. Women will be ran-
domized to a treatment group within each community
outreach recruitment event. This stratified random sam-
pling design will minimize the variation between the
MI2 and C intervention arms by allocating the variation
between each Northeast and Southwest Kansas recruit-
ment event to the strata parameters. In doing so, the
variation between interventions will be minimized,
much like a randomized complete block design.
Healthy Living Kansas-Breast Health Computer Program
Development
Computer Program Notebook computer will be used to
conduct the Healthy Living Kansas-Breast Health
(HLK-BH) program. Notebook software interfaces will
be programmed by personnel from the University of
Kansas (KU) Design for Health group - a network of
communications, information technology, and web
design professionals that have collaborated with our
Healthy Living Kansas research team over the past sev-
eral years. We anticipate that the HLK-BH program will
be conducted on an electronic computer platform but
will ask Latina and American Indian community mem-
bers to decide whether they would prefer an Internet-
enabled or notebook PC-based program (where data are
saved on the computer and not uploaded to the Inter-
net). For individuals reticent with completing the HLK-
BH program via any electronic format, we will have a
paper and pencil version available as well. The KU
Design for Health staff will utilize their graphic design
and effective communication campaign knowledge to
ensure that the final HLK-BH product has a crisp, user-
friendly look to it while still being easily navigable. With
the input of community members, we will work to make
the program culturally sensitive by having two programs
with identical data elements but one tailored to Latinas
and the other tailored to American Indian women. Each
program will also be enhanced with clickable voice and
video clips in English and Spanish to assist participants
with lower literacy levels. Program team members will
work to achieve a notebook product that has high lit-
erary contrast, readable font type and functional font
size with an overall presentation that is complete with
compatible non-glaring hues and tones.
Healthy Living Kansas Breast Health Assessment
(HLK-BH) Study investigators have collaborated to
develop a comprehensive cancer assessment for use in
our current Healthy Living project. The breast cancer
questions contained in the previously developed can-
cer assessment will provide the platform from which
the research team will develop the HLK-BH program
for the notebook computers used in the proposed
study.
HLK-BH Part I
Part I of the HLK-BH program will begin by screening
for eligible study participants. Eligible participants will
be 40-74 years of age and not up-to-date on breast can-
cer screening as defined by the American Cancer
Society. Persons who are 40-74 years of age or older but
who report being up-to-date on breast cancer screening
will receive a one-page on-screen summary report that
indicates they are up-to-date on breast cancer screening
and reinforces their healthy breast behavior. Persons
deemed eligible (i.e., meet age and breast cancer screen-
ing criteria) will continue with Part II of the HLK-BH
program.
HLK-BH Part II
Part II of the HLK-BH program will begin with an on-
screen consent procedure. The research team currently
uses an on-screen consent procedure in our Healthy
Living project (described in the Preliminary Studies sec-
tion). If a participant does not consent to the study, she
will immediately receive an on-screen summary report
that promotes breast cancer screening, and describes
why being up-to-date with breast cancer screening is
important. Consenting participants proceed with
answering questions about breast cancer screening
awareness, breast cancer testing preferences, breast can-
cer screening barriers, perceived breast cancer suscept-
ibility, screening self-efficacy, and breast cancer risk
status. Demographic questions will assess marital status,
employment status, years of education, income, race,
and ethnicity.
Whenever possible, HLK-BH questions will be adapted
from already existing and validated questions from
widely used surveys (e.g., Behavioral Risk Factor Surveil-
lance System Survey, National Health Interview Survey).
Members of the Community Advisory Boards will
review all components of the HLK-BH and notebook
computer presentation to identify ways in which it may
be improved. Previous studies conducted by the research
team using computer tablets and tablets in primary care
practices revealed the importance of keeping assess-
ments brief. The research team will strive to restrict the
assessment to 10-20 minutes. All HLK-BH questions
will be subjected to computer readability analyses. We
will use computer software developed by Readability
Calculations that assesses text readability using nine
recognized formulae [52].
The full HLK-BH tablet program will be pilot tested
with community members to ensure that the program
length is manageable and is running smoothly. Persons
who participate in the HLK-BH notebook computer
pilot will not participate in the proposed randomized
trial. The research team will work with the advisory
boards and community members to develop additional
methods to assure assessment brevity.
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Community Health Worker Training
CHWs will be trained and meet compliance criteria prior
to recruiting study participants. Training elements will
include: 1) reviewing the implementation intentions pro-
tocol manual, 2) reading a training workbook with a ser-
ies of publications and reviews of breast cancer screening
guidelines, breast cancer screening intervention studies,
implementation intentions theory, and Health Education
theory, 3) participating in training sessions conducted by
study investigators, 4) conducting simulated recruitment
intervention sessions, with sessions recorded and super-
vised by the P.I., 5) participating in follow-up training
sessions conducted by study investigators, and 7) partici-
pating in ongoing evaluation by the P.I.
Training content will include the theoretical models
and key principles underlying implementation intentions
and the intervention overview. In addition, the study P.I.
will train CHWs to respond to participant concerns
regarding breast cancer screening and interaction with
the health care system (e.g., exam initiation, procedural
details, follow-up). CHWs will be trained to educate par-
ticipants about approaching their physician or ancillary
staff to request a mammogram referral, how to address
concerns with exam procedures and, when to refer parti-
cipants to their physician for questions and concerns
related to breast cancer screening. To ensure CHWs are
adequately trained, they will conduct practice sessions
with each other, with volunteer participants, and with
pilot participants prior to recruiting participants for the
study. These sessions will be videotaped and the P.I. and
Project Director will conduct supervisory sessions to pro-
vide guidance and feedback to the CHWs.
For purposes of CHW training and ensuring fidelity to
principles and protocols of the implementation intentions,
we will use a rating form adapted from our recent Healthy
Living Kansas colon cancer screening study. Adherence to
CHW principles will be rated on a 1-7 (Poor/Never to
Excellent/Always) scale. Scores of 4 or higher represent
adherence at the level of “good” or “often”. Acceptable
performance will be indicated by a mean score of 5 or
higher with no score on any criterion being below 3.
CHWs will have to achieve acceptable performance across
all criteria on three consecutive practice participants
before being permitted to recruit participants. If perfor-
mance drops below the threshold (i.e., a mean of five and
a minimum of three on all criteria), additional supervision
will be conducted. Each of the CHWs subsequent sessions
will then be supervised until three consecutive tapes again
meet the threshold.
Study 2. Randomized Trial
Participant Eligibility
Eligibility criteria for randomized trial participation
include: individuals must be 40 years of age or older
and not up-to-date with breast cancer screening as
defined by current American Cancer Society recommen-
dations (see Table 2). Individuals with an acute medical
illness or a history of breast cancer will be excluded
from the study. Although no formal assessment of
dementia or psychiatric illness will be performed, parti-
cipants demonstrating impaired cognitive function or
inappropriate affect or behavior will be excluded from
the study. Individuals with another household member
enrolled in the study also will be ineligible. Individuals
who have been enrolled in the study will not be eligible
for repeat enrollment. This is true even if greater than
one year has passed since their initial participation. Any-
one not eligible for the study but interested in breast
cancer screening and information will be given printed
self-help materials (What you need to know about Breast
Cancer, National Cancer Institute, Breast Cancer and
You, Centers for Disease Control). Participants must
have a current, active mailing address and access to a
functioning telephone to ensure that the 120 day tele-
phone follow up can be completed.
Availability of Participants
We will recruit and randomize a total of 290 participants
(145 randomized to the MI2 arm and 145 randomized to
the C arm). Participants will be recruited from annually
scheduled and well attended community events in and
around the Mayetta and Garden City, KS communities.
Garden City is the Finney County seat. Approximately
50% of the county population, and Garden City’s popula-
tion, is non-Hispanic White while 45% of the nearly
41,000 people living in Finney County are Latino
(approximately 9,000 Hispanic/Latina females). Our
American Indian recruitment in Northeast Kansas will
include a five county region; Brown (pop. 10,009/52%
female/9% AI/AN); Jackson (pop. 13,240/50% female/7%
AI/AN); Doniphan (pop. 7,753/51% female/2% AI/AN);
Jefferson (pop. 18,421/50% female/1% AI/AN); and Potta-
watomie (pop. 19,695/50% female/1% AI/AN). The
Table 2 Participant Eligibility
Inclusion Criteria Exclusion Criteria
• Latina or AI/AN woman residing in one of participating communities
• Aged ≥40 years of age
• Not up to date on mammography screening
• Home address & access to a working telephone
• Responded to 120-day post randomization follow-up call
• Receipt of mammogram within past year
• Acute medical illness, history of breast cancer
• Cognitive impairment or inappropriate affect or behavior
• Another household member enrolled in the study
Engelman et al. BMC Public Health 2011, 11:47
http://www.biomedcentral.com/1471-2458/11/47
Page 8 of 17
AI/AN female population in each county is: Brown =
470; Jackson = 452; Jefferson = 100; Potawatomie = 69;
and Doniphan = 58.
Annual community events are common within both
target communities. Amongst other events, Mayetta and
surrounding areas are home to the Prairie Band Potawa-
tomi Pow Wow (held in June) and Prairie Band Potawa-
tomi Health Fair (September), Kickapoo Pow Wow
(July), Sac and Fox Health Fair (September), and the
Ioway Health Fair (October). Garden City and its
surrounding communities is home to a Cinco de Mayo
celebration (May), Community Mexican Fiesta (Septem-
ber), Tyson Health Fair (October), Binational Health Fair
(October), and several community events sponsored by
the six area churches. Using three CHWs per commu-
nity, we anticipate being able to recruit approximately
150 women in each community. If, upon a midcourse
evaluation, we determine that recruitment is behind
schedule, we will supplement our recruitment efforts by
partnering directly with health clinics in our target com-
munities to recruit within clinic waiting rooms.
CHW/Participant Partnership Implementation Intentions
(MI2) Intervention
Each participant in the MI2 intervention arm will
receive brief one-on-one breast cancer screening edu-
cation delivered in person by a CHW. Following the
education information delivery, the CHW will guide
participants through the Healthy Living Kansas-Breast
Health computerized screening and intervention pro-
gram. This program will guide participants through a
screening/eligibility assessment and implementation
intentions protocol via automated computerized algo-
rithms. If, upon screening, a person is deemed eligible
to participate in the randomized trial (e.g., they are
eligible for but not up to date on breast cancer screen-
ing), the computer program will automatically and
immediately assign them to either the intervention or
control arm. The total time required per participant to
complete the education session and HLK-BH notebook
computer program will be kept to a maximum of
20 minutes.
For persons who are randomized to the MI2 interven-
tion arm, the HLK-BH program will guide participants
through a series of implementation intentions questions
to fully delineate step-by-step breast cancer screening
intentions of participants (the when, where and how of
screening) and encourage follow through on these inten-
tions. Breast cancer screening information, relevant to
the stated intentions of the participant will then be
delivered over the remaining course of the program.
Implementation intentions questions and breast cancer
screening information in the HLK-BH program will be
adapted with input from community and advisory board
members and from questions and materials used suc-
cessfully in our prior implementation intentions-based
cancer screening studies. The HLK-BH program will, by
necessity, consist of two primary phases designed to: 1)
elicit participants’ implementation intentions and 2)
encourage follow through. Although implementation
intention tasks will differ for each participant, a sample
list of tasks is presented in Table 3. In a typical program
session, participants will be asked to declare whether
they “intend” to get breast cancer screening. If they are
unsure or do not intend to get screened within the next
120 days, they will be taken through a series of imple-
mentation intention questions that specifically address
when, where, and how they will gather more informa-
tion on breast cancer screening or engage in discussions
about breast cancer screening with their physician,
family, or peer group. Individuals intending to receive
screening will be led through a series of questions
about when, where, and how they will be screened. The
questions will include specifics on making contacts with
the health care system, obtaining authorizations from
health care providers, scheduling appointments, arran-
ging for transportation to mammography locations, and
avoiding potential behavioral pitfalls along each juncture
of the aforementioned process. All implementation
intention questions will be tailored to the race/ethnicity
of the participant. The HLK-BH program also will pro-
vide suggestions that might help the participant over-
come obstacles to test completion (inconvenience, pain,
Table 3 Sample Implementation Intention Task Analyses for MI2 Participants
Participants “Unaware” Stage for Breast Cancer Screening Participants “Decided/Deciding” About Breast Cancer
Screening
• Identify a source for more breast cancer information
• Specify a goal date by which the breast cancer information source will be
contacted
• Identify steps necessary to contact the breast cancer information source (e.g., if
breast cancer information source is a health care provider: obtain telephone
number, schedule an appointment, arrange transportation to and from the
appointment if necessary)
• Identify breast cancer screening questions to ask
• Describe how information gathered will be saved and additional contacts who
may be used as “second opinions”
• Identify health professional that will supply mammography
referral, if necessary
• Declare how to request a referral
• Assess insurance status
• Identify eligibility for Early Detection Works program
• Telephone to schedule exam (e.g., who to call, number to call,
information to have available to schedule exam)
• Identify exam preparation tips to increase comfort
• Arrange transportation to and from appointment if necessary
• Arrange for child care if necessary
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embarrassment). To assist persons with low literacy
levels, the computer program will evaluate and organize
data as they are entered and then deliver a tailored
intervention message using video clips and narrated gra-
phics. In this manner, the program will select messages
that are tailored to race/ethnicity and gender matched
to individual participants. Participants will wear head-
phones. The primary goal of the HLK-BH program for
MI2 participants is to clarify implementation intentions
and address barriers which might prevent follow
through on these intentions.
Immediately following completion of the HLK-BH ses-
sion, participants will receive a printed “Implementation
Intentions Confirmation Contract” that will serve as a
final indicator of the stated and agreed to plan that the
HLK-BH session produced. This contract will serve as a
written reminder and reinforcement for each partici-
pant’s breast cancer screening implementation inten-
tions and will be tailored to each individual’s Precaution
Adoption Process Model behavioral stage of readiness.
As with the notebook computer screens, the KU Design
for Health unit will work with us to ensure the delivery
of high quality, highly readable and usable printed
contract.
Control Arm (C) Intervention
Each participant in the C intervention arm will receive
the same brief one-on-one breast cancer screening edu-
cation information delivered in person by a CHW as
MI2 participants. Following the education information
delivery, the CHW will guide participants through the
Healthy Living Kansas-Breast Health computerized
screening and intervention program. This computerized
program will guide participants through a screening/
eligibility assessment and additional breast health and
screening education protocol. If, upon screening, a per-
son is deemed eligible to participate in the randomized
trial (e.g., they are eligible for but not up to date on
breast cancer screening), the computer program will
automatically and immediately assign them to either the
intervention or control arm. The C intervention will
also be infused with audio-narratives delivered by a
non-matched clinician reader. This clinician will read
textual material comparable to that provided in educa-
tional pamphlets distributed by the NCI and Centers for
Disease Control. The information will cover prevalence
and distribution of breast cancer, rates of mortality, the
potential mortality reduction with early detection, early
signs and symptoms of breast cancer, and primary pre-
ventive measures for reducing the incidence of breast
cancer. A small amount of supplemental material may
be provided to assure that the length of this session
matches the length of the multimedia session provided
to MI2 participants. As with MI2 participants, the total
time required per participant to complete the education
session and HLK-BH computer program will be kept to
a maximum of 20 minutes.
During the control arm HLK-BH program, partici-
pants will be reminded of the importance of breast can-
cer screening and highlight NCI-recommended healthy
breast behaviors such as regular physical activity and a
diet rich in fruits and vegetables. These HLK-BH ses-
sions will rely on a “health educator” methodology.
Furthermore, the CHW will be instructed to not initiate
specific behavioral advice or use behavioral counseling
strategies following participant completion of the con-
trol arm HLK-BH program. If, however, a participant
asks for specific behavioral advice related to the formu-
lation of implementation intentions, the CHWs will
answer the participant’s question briefly and document
the question and their reply.
All participants (intervention and control) will
received a $25 gift card to reimburse them for their
time involved with completing the HLK-BH program
assessment.
120-Day Post Randomization Follow-Up
All MI2 and C participants will receive a follow-up tele-
phone call from a CHW to reassess breast cancer
screening status. For example, participants will be asked
if screening was performed within the last 120 days
since the initial intervention, and if so, when it was per-
formed, and when the participant plans to have their
next routine breast cancer screening examination. The
CHW also will re-administer portions of the HLK-BH
program questions via the telephone and ask questions
regarding breast cancer testing utilization, breast cancer
screening barriers, perceived breast cancer susceptibility,
screening self-efficacy, and breast cancer risk status and
reassess Precaution Adoption Process Model behavioral
breast cancer screening stage. Program evaluation and
satisfaction questions will also be asked of each partici-
pant near the end of this final assessment. By re-admin-
istering portions of the HLK-BH program questions at
the 120-day post randomization follow-up, the research
team will be able to evaluate the differential impact of
the MI2 intervention compared to the C intervention on
the primary (e.g., breast cancer screening utilization)
and secondary outcomes (e.g., breast cancer screening
barriers and progression through the PAPM stages).
Refer to Figure 2 for an overview of the flow of research
participants.
Project Instrumentation
The purpose of all survey project instrumentation is to
collect data for use in developing individually tailored
materials and to allow for analysis of study main effects
with appropriate covariate controls. The measured con-
structs should also provide information on which vari-
ables are responsible for intervention effects. All
measures except for “Implementation Intentions”
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measures will be given to study participants prior to
randomization and thus to participants in both arms
(MI2 and C).
Though many of the scales and instruments selected
for the study have been used in previous studies, the
complete baseline survey instrument will be pilot tested
with Latina and female AI/AN community members
within our two target communities. Feedback from this
pilot testing phase will be used to revise the instrument
and to prepare it for administration. Our goal is to
establish an instrument that can be completed in 10-15
minutes using a notebook computer.
Demographics
Data on gender, education, marital status, age, income,
employment status, and race/ethnicity will be collected.
With respect to race/ethnicity, study participants will be
asked to identify themselves as being Black/African
American (and allow for further ethnic identification as
U.S. born, Caribbean immigrant, African immigrant,
Jamaican, etc.), Hispanic, White, Native American/
American Indian, Asian, or Other [53].
PAPM Stage
The model’s authors provide a staging algorithm and
recommended question formats for staging other health
behaviors [40,54]. We will adapt the staging questions to
breast cancer screening and use a six-item scale: “Have
you ever heard about breast cancer screening?"; “Have you
been tested for breast cancer?” and “Which of the follow-
ing best describes your thoughts about getting tested for
breast cancer: I’ve never thought about it, I’m undecided,
I’ve decided I don’t want to, I’ve decided I want to get
tested.” Necessarily, stage will be asked prior to the beha-
vior questions so that responses are not influenced or
triggered by the questions about specific screening tests.
Perceived Susceptibility to Breast Cancer, Perceived
Screening Benefit, and Screening Barriers
We will utilize the Revised Susceptibility, Benefits, and
Barriers Scale developed by Champion [55]. This 19 item
Figure 2 Flow of Participants.
Engelman et al. BMC Public Health 2011, 11:47
http://www.biomedcentral.com/1471-2458/11/47
Page 11 of 17
scale has been used widely by researchers and has shown
to be a reliable and valid assessment.
Self-Efficacy to Complete Mammography
A single item ("how confident are you that you can
complete breast cancer screening?”) [8] will be com-
bined with a four-item scale that showed excellent inter-
nal consistency (alpha = 0.82) and factor loadings from
0.65-0.68 in a confirmatory factor analysis [56].
Prior Breast Cancer Screening Test Utilization
Participants will be asked if they have ever been
screened for breast cancer and how long ago the test
was received. This nine-item set of questions has been
used in pilot studies by the research team [50] and was
adapted from Behavioral Risk Factor Surveillance System
questions. This set of questions will also ask whether or
not a participant has undergone any breast cancer test-
ing for diagnostic purposes.
Cancer Fatalism
We will employ an adapted Powe Cancer Fatalism
inventory to evaluate beliefs toward early detection,
treatment, and cancer myths (10 questions).
Implementation Intentions - only delivered to MI2
participants
Implementation intentions measures have been adapted
from the work of Gollwitzer and Sheeran, et al [30,39].
To assess Pre-Action/Pre-contemplation Implementa-
tion Intentions, participants will be asked where, when,
and how they will seek out more information on breast
cancer prevention ("do you think you will try to get
more information about breast cancer?” “Do you believe
you will talk to any of the following individuals about
breast cancer prevention?” “Can you pin down a date
you think you will first talk to this person about breast
cancer prevention? ___/____/______”). For Action/Con-
templation Implementation Intentions, participants will
be asked specific action-oriented questions regarding
mammography. A participant who describes an inten-
tion to complete screening mammography may also be
asked (among other things) to set a specific date they
plan to be screened, whether they need to get a health-
care provider referral, what mammography facility they
will call to set up their appointment (the telephone
number will be supplied to participants automatically by
the HLK-BH program once a facility is selected).
Process Evaluation It is necessary to document and
analyze the process of program implementation to verify
the integrity of the intervention, allow for correction of
problems as they occur, provide data to examine the
relationship between program delivery and program out-
comes, and to guide future investigations [57-59].
Therefore, a comprehensive set of process assessments,
including both qualitative and quantitative data, will be
designed or adapted from previous studies to measure
implementation, participation, and fidelity.
We plan to measure characteristics of the participants
and community health and environmental issues that
may influence breast cancer screenings. In addition, we
will collect information that may provide useful insight
into refining protocols and materials. Another aim of
the evaluation is to provide a general description of the
context in which the intervention is conducted. Table 4
summarizes the variables to be measured and the data
collection instruments to be used.
Community Participants
We will assess the ability of the participants to use the
notebook computer by direct observation and follow-up
with questions regarding the ease of use during our
planned exit survey. In addition to demographic charac-
teristics, we will collect type of insurance coverage,
which has been found to have a differential effect on
cancer screenings [60]. The Community Health Workers
will perform these observations. We will also determine
if screening rates could be affected by dominant mam-
mography facilities distributed asymmetrically across our
target communities [61], number of miles to screening
mammography facilities, and level of perceived discom-
fort with screening procedure, etc. To identify issues
related to perceived benefits and challenges, we will ask
a subsample of participants about the helpfulness, rele-
vance, convenience, level of satisfaction, etc. of their
Healthy Living Kansas-Breast Health program Commu-
nity Health Worker. Measuring participant’s satisfaction
and soliciting information about potential benefits and
barriers will provide valuable feedback about the extent
Table 4 Summary of Process Evaluation Measures
Source Instruments Variables of Interest
Participants HLK-BH program; 120 day follow-up telephone call Demographics, ease of use of notebook computer, type of insurance
coverage (i.e., Medicare, uninsured, commercial), new/emerging illness,




CHW training session tracking form; attendance
records
Attendance at training sessions, turnover, transfers, level of support for




Indian Health Service & United Methodist Mexican
American Ministries Clinic Director questionnaire
Programs/Information/Policies designed to increase breast cancer
screenings not initiated by us
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to which the activities have met with patient expecta-
tions [62]. We will use structured interviews to be
completed during the end of the study to determine
benefits and barriers, helpfulness of Community Health
Workers, why they did or did not get screened, and
whether or not they would recommend the program to
others. These random assessments will be conducted via
telephone for 10% of participants.
Community Health Workers
The quality and integrity of the HLK-BH program will
be partially dependent on how the CWHs carry out the
education and recruitment sessions. The ability of the
CHW to conduct activities consistent with program
goals will vary across workers. This variation will be
related to a number of factors including training, self-
efficacy, number of years experience, understanding of
the overall program, and level of perceived support. We
will administer a training workshop survey to the
CHWs during the training session to document their
attendance and their level of support for and importance
of the HLK-BH screening program. Further, we will
assess the CHW’s level of confidence to implement the
research protocol as designed. In addition, we will track
turnover and/or transfer rates to document potential
study personnel issues and track CHW participation in
weekly group teleconference calls, encrypted data trans-
fers, and recruitment logs. We will assess these factors
by administering a questionnaire to all CHWs involved
in the study.
HLK-BH Components
We will use a number of different strategies to docu-
ment the degree to which the research protocol was
implemented as planned. For example, each notebook
computer or HLK-BH Internet program will track the
amount of time to complete the HLK-BH assessment.
We will also assess the number of individuals who were
ineligible for the intervention program because they
self-reported being in compliance with screening guide-
lines, already had a screening appointment scheduled,
had an acute and/or terminal medical condition at the
time of their recruitment interaction with a CHW.
External and Competing Programs
We will ask mammography facility personnel local to
Mayetta and Garden City, KS to complete a short ques-
tionnaire to assess whether their facility received any
breast cancer-related information not related to our pro-
ject, which was shared with patients, or if promotional
activities were conducted to increase breast cancer
screenings, in addition to our research project during our
study time period, which might serve to contaminate or
lessen program effects. Information gained will be used
to help us determine if external or competing factors
might have influenced breast cancer screening objectives,
posing as possible internal validity threats [63].
Process Evaluation Analysis
We have planned process evaluation procedures to pro-
vide detailed information regarding the intervention
implementation. The process evaluation will include
paper and pencil surveys, structured interviews, and
monitoring logs to collect quantitative and qualitative
data on specific program components and implementa-
tion issues. Monitoring the extent and quality of imple-
mentation will allow us to guard against “Type III
Error” in which an intervention, not fully implemented
as planned, is not a true test of the experimental
hypotheses [64].
Descriptive statistics will be used to provide a general
description of the context in which the intervention is
being conducted (e.g., participant, CHW, and commu-
nity recruitment setting characteristics). Individual char-
acteristics, for example, may contribute to or detract
from intervention effects. To monitor intervention com-
ponents across recruitment communities and exposure
to program elements, we will develop estimates of
adherence rates from survey information and self-report
measures, magnitude of intervention effects and the
variability of outcome.
The content of comments from structured interviews
completed by participants will be examined for com-
mon themes related to recommendations for improv-
ing training protocols and materials, and factors
related to implementation of the screening program.
Comments will be analyzed by employing the content
analysis techniques recommended by Miles [65]. Iden-
tification of and suggestions for the removal of barriers
to participation, and for procedures to enhance adher-
ence will be summarized to allow for midcourse cor-
rections in implementation, to refine the intervention
design, and to provide direction to our intervention
strategies [66].
Study 3: Data Analysis and Dissemination
Data Analysis
Descriptive statistics will be generated from the sample
using the demographic measures. Pearson’s c2 test will
be used to compare the proportions of categorical char-
acteristics between the two intervention groups. The
two-sample t-test will facilitate the comparison between
the groups for characteristics measured on a continuous
scale. This will allow us to evaluate the randomization,
as we would expect to find roughly 5% of these findings
to be statistically significant at the a = 0.05 level.
Aim #1 To compare the 120-day post randomization
mammography screening completion rates of individuals
who receive a computerized mammography “implemen-
tation intentions” (MI2) intervention, versus a compari-
son computerized condition of general breast cancer
prevention health education (C).
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For this aim, both the outcome (120-day post randomi-
zation breast cancer screening completion) and predictor
(treatment group) are dichotomous, so a 2 × 2 table will
be generated to compare the proportions of those com-
pleting screening between the MI2 versus C intervention
groups. A c2 statistic will be used to test the null hypoth-
esis of no difference in these proportions between these
two [67]. The distribution of measured and unmeasured
confounding variables (beyond community location)
should be relatively balanced between the intervention
groups due to the random assignment of the intervention
within communities and participants. However, if serious
imbalances are apparent from the descriptive statistics
described above, we will use unconditional logistic
regression to model this dichotomous outcome. Predictor
variables will include the intervention group and the
unbalanced demographic characteristics to reduce the
impact of such biases. Indicator variables identifying the
community will also be included to control for this strati-
fication variable as described by Agresti [67]. The results
of this logistic regression will be transformed into esti-
mates of the proportion screened [68] adjusted for the
potential confounding variables. The fit of the model will
be assessed using the Deviance statistic and the Hosmer-
Lemeshow goodness-of-fit test [68].
To measure the impact of attrition on the part of the
study participant, a sensitivity analysis will be per-
formed. This can be done using the methods described
by Rothman and Greenland [69] by examining what the
results would be under various assumed scenarios for
those missing the outcome. This will include a conserva-
tive imputation approach which will assume that all of
those for whom this outcome is unknown were not
screened during the 120-day post randomization period.
Aim #2 To compare the screening mammography self-
reported barriers after 120-days post randomization
between those receiving a mammography “implementa-
tion intentions” intervention (MI2) and those receiving
only a general breast cancer prevention health education
intervention (C).
The outcome for this aim, self-reported barriers, takes
integer values from zero to eleven. To analyze this out-
come, we will use a two-sample t-test. If gross non-
normality is present and Wilcoxon Rank Sum test will
be used. In addition to testing the main effect of treat-
ment group, the interaction between treatment arm and
120-day breast cancer screening status will also be
investigated to determine whether there is a greater
reduction in barriers among screeners from the MI2
group relative to screeners from the C group. In the
presence of serious imbalances despite the randomiza-
tion, additional predictor variables can be incorporated
into this analysis using multiple regression assuming the
normality assumption holds. If not, appropriate power
transformations will be used on the dependent variable
prior to modeling.
Aim #3 To compare changes in mammography screen-
ing Precaution Adoption Process Model decisional stage
from baseline to 120 days post randomization between
individuals in the MI2 and C study arms.
The PAPM outcome is a six-level ordinal measure
and the predictor (treatment group) is dichotomous, so
a 2 × 6 table will be generated. The Cochran-Armita-
gestatistic will be used to test the null hypothesis of no
difference in the distribution of scores between these
two groups versus a trend [70]. If serious imbalances
are apparent from the descriptive statistics described
above, we will use the cumulative logit model [67]. Pre-
dictor variables will include the intervention group and
the unbalanced demographic characteristics to reduce
the impact of these biases. Indicator variables identify-
ing the community will also be included to control for
this stratification variable as described by Agresti [67].
The results of this regression will be transformed into
estimates of the proportion moving from one stage to
the next, adjusted for the potential confounding vari-
ables. The fit of the model will be assessed using the
Deviance statistic.
Sample Size and Sample Size Justification
This study will utilize Latina and AI/AN female partici-
pants from two distinct communities with approxi-
mately 121 randomized participants per community to
test the main effects of the MI2 vs. C arms at 120 days
post randomization. For this study, a total of 290 sub-
jects will be randomized to either the MI2 or C treat-
ment arms (to account for a possible 20% attrition rate
from randomization to 120 day follow up). It is antici-
pated that 30% of those in the MI2 group will receive
their breast cancer screening within the 120 day study
period compared to 15% in the C group. A total of 242
subjects (121 per study arm) would have 80% power to
detect the anticipated difference in screening rate
between the MI2 and C groups at the a = 0.05 (two-
sided) type I error rate (Table 5). Assuming up to a 20%
attrition rate based on the research team’s prior studies
in rural Kansas, a total of 290 subjects will be rando-
mized to either the MI2 or C treatment arms (145 per
treatment). Additional screening rates were examined
for study power (Table 5) to select an adequate sample
Table 5 Power estimates (%) for a sample size of 121
subjects per group with a = 0.05 (two-sided)
Breast Cancer Screening -
Implementation Intentions
25% 30%
Breast Cancer Screening 10% 87 97
Controls 15% Not Relevant 80
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size to detect clinically relevant differences. Numbers
contained in Table 5 demonstrate that the sample will
have at least 80% power to detect clinically relevant dif-
ferences. Similar tables to Table 5 were also compared
with varying sample sizes, with the final sample size
selected being the choice that optimized both study
power with the logistical constraints.
Basis for projected breast cancer screening rates
In general, the literature shows that approximately 42%
of Latina and 47% of American Indian/Alaskan Native
women aged 40 years or older have been screened
recently.
Basis for intervention impact estimate
A study utilizing breast cancer survivors to serve as pro-
motoras (similar to our community health worker para-
digm proposed in this study) to promote breast cancer
screening resulted in a 21% uptake in screening among
141 Latina women [71]. In a separate study with Native
American women, a face-to-face patient navigator breast
cancer education intervention resulted in a 11% uptake
in screening mammography [72]. We expect a similar
screening mammography uptake rates in our proposed
study.
Screening uptake data from our current Healthy Liv-
ing Kansas colorectal cancer implementation intentions
intervention study are not yet available. However, other
implementation intention-based studies have shown
positive improvements in dietary fat intake [37], vitamin
supplement intake [33], breast self-examination rates
[34], vigorous physical activity rates [35], and functional
ability after surgery [36]. Sheeran and Orbell [30] con-
ducted a study to investigate the impact of an imple-
mentation intention intervention on cervical cancer
screening rates - a behavior similar to the primary out-
come of the proposed study, breast cancer screening.
Sheeran and Orbell found the implementation intention
intervention to increase cervical cancer screening atten-
dance by 23% compared with a control group. Another
recent study to assess the effect of implementation
intentions on testicular self examination (TSE) in men
found a 25% increase in self-reported TSE vs. a no inter-
vention group. Both studies represent substantial beha-
vioral changes resulting from implementation
intentions-based interventions. Based on these studies,
we would anticipate a similar increase in breast cancer
screening in a general population. However, the partici-
pants who will be randomized into one of the proposed
study arms represent traditionally underserved rural
minority women whose access to mammography ser-
vices may be hampered. Thus, we would expect for it to
be more difficult to alter their breast cancer screening
behavior. Nonetheless, based on the aforementioned
assumptions, we anticipate a 25% increase in CRC
screening rates for MI2 participants versus a 10%
increase in breast cancer screening rates for C
participants.
Discussion
In the U.S., women from Hispanic or American Indian/
Alaskan Native racial/ethnic backgrounds have dispro-
portionately low breast cancer screening rates. Later
stage cancers also have been found among persons
living in rural communities. Not unlike other states,
Kansas has seen recent unprecedented growth of under-
served rural Latino and American Indian communities.
Simple ‘one size fits all’ programs to overcome barriers
to breast cancer screening are likely not to be effective
within these communities given their diverse cultures
and unique mammography access issues. To be maxi-
mally effective, programs to promote breast cancer
screening in these communities will need to be cultu-
rally relevant, pertinent to the specific concerns of indi-
vidual community members, and provide clear direction
regarding steps that advance program participants
towards their intended goal. There is good empirical
evidence to suggest that a program with implementation
intention components (e.g., one that lays out the where,
how, and when steps to screening) will be an effective
method for addressing breast cancer screening underuti-
lization. In this study, we propose to test such an ‘imple-
mentation intentions’ based method that is firmly seated
in health behavior theory, culturally relevant, commu-
nity specific, and guided and introduced by Latina and
AI/AN community health workers in two distinct rural
communities. The conduct of this study will move us
forward in our understanding of how best to improve
breast cancer screening utilization among underserved
minority and rural-dwelling individuals. This type of
intervention also is significant in that it is generalizable
to organizations such as health plans or existing 1-800
cancer information telephone programs that have the
capacity to adopt similar telephone-based counseling
procedures to promote cancer screening utilization.
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